Aptevo Therapeutics Inc. (APVO) — S-1 Filings
All S-1 filings from Aptevo Therapeutics Inc.. Browse 8 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (8)
-
Aptevo Registers 6.9M Shares for YA Resale, Securing $25M Equity Line
— Oct 1, 2025 Risk: high
Aptevo Therapeutics Inc. (APVO) filed an S-1 on October 1, 2025, to register 6,903,755 shares of common stock for resale by YA II PN, LTD. (YA). These shares ar -
Aptevo Files S-1 for Continuous Offering, Signaling Future Capital Raise
— Jul 25, 2025 Risk: medium
Aptevo Therapeutics Inc. filed an S-1 registration statement on July 25, 2025, for a proposed sale of securities on a delayed or continuous basis, indicating a -
Aptevo Files S-1 for Continuous Offering, Signaling Capital Raise
— Jun 16, 2025 Risk: medium
Aptevo Therapeutics Inc. filed an S-1 on June 16, 2025, for a delayed or continuous offering of securities, indicating a potential capital raise to fund its ope -
Aptevo Therapeutics Files S-1 for Securities Offering
— May 13, 2025 Risk: medium
Aptevo Therapeutics Inc. filed an S-1 registration statement with the SEC on May 13, 2025, to register an unspecified number of securities. The company, headqua -
Aptevo Therapeutics Files S-1 for Future Offering
— Mar 3, 2025 Risk: medium
Aptevo Therapeutics Inc. filed an S-1 registration statement on March 3, 2025, for an unspecified offering. The company, incorporated in Delaware with its princ -
Aptevo Therapeutics Files S-1 with SEC
— Aug 30, 2024 Risk: medium
Aptevo Therapeutics Inc. filed an S-1 registration statement on August 30, 2024, with the SEC. The company, incorporated in Delaware and headquartered in Seattl -
Aptevo Therapeutics Files S-1 Registration
— Jun 14, 2024 Risk: medium
Aptevo Therapeutics Inc. filed an S-1 registration statement on June 14, 2024, to register an unspecified number of securities. The company, incorporated in Del -
Aptevo Therapeutics Inc. Files S-1 Registration Statement
— Mar 20, 2024 Risk: medium
Aptevo Therapeutics Inc. (APVO) filed a IPO Registration (S-1) with the SEC on March 20, 2024. Aptevo Therapeutics Inc. filed an S-1 registration statement with
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX